Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Tollefson

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Psychiatry|April 7, 1999
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?G D Tollefson, S W Andersen
Journal of Clinical Psychopharmacology|February 1, 1982
Indomethacin and prostaglandins: their behavioral relationships in an acute toxic psychosisG D Tollefson, M J Garvey
The British Journal of Psychiatry. Supplement|April 22, 1999
Review of recent clinical studies with olanzapineG D Tollefson, A J Kuntz
Psychosomatics|May 1, 1982
Depressive episodes following alcohol intoxicationM J Garvey, G D Tollefson
The New England Journal of Medicine|April 6, 1995
FluoxetineS L Blomgren, G D Tollefson
International Clinical Psychopharmacology|January 1, 1994
How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placeboG D Tollefson, S L Holman
The American Journal of Psychiatry|March 1, 1988
Alprazolam plus buspirone in treatment of anxietyG D Tollefson, J Montague-Clouse
Archives of General Psychiatry|March 1, 1987
Occurrence of myoclonus in patients treated with cyclic antidepressantsM J Garvey, G D Tollefson
Journal of Clinical Psychopharmacology|August 1, 1983
A comparison of first and second generation antidepressants at the human muscarinic cholinergic receptorG D Tollefson, S E Senogles
The American Journal of Psychiatry|April 1, 1997
Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapineG D Tollefson, T M Sanger
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Psychiatry|April 7, 1999
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?G D Tollefson, S W Andersen
Journal of Clinical Psychopharmacology|February 1, 1982
Indomethacin and prostaglandins: their behavioral relationships in an acute toxic psychosisG D Tollefson, M J Garvey
The British Journal of Psychiatry. Supplement|April 22, 1999
Review of recent clinical studies with olanzapineG D Tollefson, A J Kuntz
Psychosomatics|May 1, 1982
Depressive episodes following alcohol intoxicationM J Garvey, G D Tollefson
The New England Journal of Medicine|April 6, 1995
FluoxetineS L Blomgren, G D Tollefson
International Clinical Psychopharmacology|January 1, 1994
How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placeboG D Tollefson, S L Holman
The American Journal of Psychiatry|March 1, 1988
Alprazolam plus buspirone in treatment of anxietyG D Tollefson, J Montague-Clouse
Archives of General Psychiatry|March 1, 1987
Occurrence of myoclonus in patients treated with cyclic antidepressantsM J Garvey, G D Tollefson
Journal of Clinical Psychopharmacology|August 1, 1983
A comparison of first and second generation antidepressants at the human muscarinic cholinergic receptorG D Tollefson, S E Senogles
The American Journal of Psychiatry|April 1, 1997
Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapineG D Tollefson, T M Sanger
Pageof 11